BACKGROUND: Despite national guidelines recommending bone mineral density screening with dual-energy x-ray absorptiometry (DXA) in women aged 65 years and older, many women do not receive initial screening. OBJECTIVE: To determine the effectiveness of health system and patient-level interventions designed to increase appropriate DXA testing and osteoporosis treatment through (1) an invitation to self-refer for DXA (self-referral); (2) self-referral plus patient educational materials; and (3) usual care (UC, physician referral). RESEARCH DESIGN: Parallel, group-randomized, controlled trials performed at Kaiser Permanente Northwest (KPNW) and Kaiser Permanente Georgia (KPG). SUBJECTS:Women aged 65 years and older without a DXA in past 5 years. MEASURES: DXA completion rates 90 days after intervention mailing and osteoporosis medication receipt 180 days after initial intervention mailing. RESULTS: From >12,000 eligible women, those randomized to self-referral were significantly more likely to receive a DXA than UC (13.0%-24.1% self-referral vs. 4.9%-5.9% UC, P<0.05). DXA rates did not significantly increase with patient educational materials. Osteoporosis was detected in a greater proportion of self-referral women compared with UC (P<0.001). The number needed to receive an invitation to result in a DXA in KPNW and KPG regions was approximately 5 and 12, respectively. New osteoporosis prescription rates were low (0.8%-3.4%) but significantly greater among self-referral versus UC in KPNW. CONCLUSIONS:DXA rates significantly improved with a mailed invitation to schedule a scan without physician referral. Providing women the opportunity to self-refer may be an effective, low-cost strategy to increase access for recommended osteoporosis screening.
RCT Entities:
BACKGROUND: Despite national guidelines recommending bone mineral density screening with dual-energy x-ray absorptiometry (DXA) in women aged 65 years and older, many women do not receive initial screening. OBJECTIVE: To determine the effectiveness of health system and patient-level interventions designed to increase appropriate DXA testing and osteoporosis treatment through (1) an invitation to self-refer for DXA (self-referral); (2) self-referral plus patient educational materials; and (3) usual care (UC, physician referral). RESEARCH DESIGN: Parallel, group-randomized, controlled trials performed at Kaiser Permanente Northwest (KPNW) and Kaiser Permanente Georgia (KPG). SUBJECTS:Women aged 65 years and older without a DXA in past 5 years. MEASURES: DXA completion rates 90 days after intervention mailing and osteoporosis medication receipt 180 days after initial intervention mailing. RESULTS: From >12,000 eligible women, those randomized to self-referral were significantly more likely to receive a DXA than UC (13.0%-24.1% self-referral vs. 4.9%-5.9% UC, P<0.05). DXA rates did not significantly increase with patient educational materials. Osteoporosis was detected in a greater proportion of self-referral women compared with UC (P<0.001). The number needed to receive an invitation to result in a DXA in KPNW and KPG regions was approximately 5 and 12, respectively. New osteoporosis prescription rates were low (0.8%-3.4%) but significantly greater among self-referral versus UC in KPNW. CONCLUSIONS: DXA rates significantly improved with a mailed invitation to schedule a scan without physician referral. Providing women the opportunity to self-refer may be an effective, low-cost strategy to increase access for recommended osteoporosis screening.
Authors: Thomas K Houston; Andrea Cherrington; Heather L Coley; Kimberly M Robinson; John A Trobaugh; Jessica H Williams; Pamela H Foster; Daniel E Ford; Ben S Gerber; Richard M Shewchuk; Jeroan J Allison Journal: J Health Commun Date: 2011-05-24
Authors: Amy S Mudano; Linda Casebeer; Fausto Patino; Jeroan J Allison; Norman W Weissman; Catarina I Kiefe; Sharina Person; Donna Gilbert; Kenneth G Saag Journal: South Med J Date: 2003-05 Impact factor: 0.954
Authors: Dennis M Black; Douglas C Bauer; Ann V Schwartz; Steven R Cummings; Clifford J Rosen Journal: N Engl J Med Date: 2012-05-09 Impact factor: 91.245
Authors: M Kastner; L Perrier; S E P Munce; C C Adhihetty; A Lau; J Hamid; V Treister; J Chan; Y Lai; S E Straus Journal: Osteoporos Int Date: 2017-10-18 Impact factor: 4.507
Authors: Maria I Danila; Ryan C Outman; Elizabeth J Rahn; Amy S Mudano; David T Redden; Peng Li; Jeroan J Allison; Fred A Anderson; Allison Wyman; Susan L Greenspan; Andrea Z LaCroix; Jeri W Nieves; Stuart L Silverman; Ethel S Siris; Nelson B Watts; Michael J Miller; Jeffrey R Curtis; Amy H Warriner; Nicole C Wright; Kenneth G Saag Journal: J Bone Miner Res Date: 2018-02-26 Impact factor: 6.741
Authors: P Cram; F D Wolinsky; Y Lou; S W Edmonds; S F Hall; D W Roblin; N C Wright; M P Jones; K G Saag Journal: Osteoporos Int Date: 2016-06-30 Impact factor: 4.507
Authors: Maria I Danila; Ryan C Outman; Elizabeth J Rahn; Amy S Mudano; Tammi F Thomas; David T Redden; Jeroan J Allison; Fred A Anderson; Julia P Anderson; Peter M Cram; Jeffrey R Curtis; Liana Fraenkel; Susan L Greenspan; Andrea Z LaCroix; Sumit R Majumdar; Michael J Miller; Jeri W Nieves; Monika M Safford; Stuart L Silverman; Ethel S Siris; Daniel H Solomon; Amy H Warriner; Nelson B Watts; Robert A Yood; Kenneth G Saag Journal: Contemp Clin Trials Commun Date: 2016-12-15